Tag: Mari Mino-Kenudson
PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC...
By Sylvie Lantuejoul, MD, PhD, and Mari Mino-Kenudson, MD
Posted: April 16, 2020
Immune checkpoint inhibitors (ICI), which target the PD-1/PD-L1 axis with the aim of...
Global Survey for Pathologists on PD-L1 Testing: Moving Toward Standardization
By Mari Mino-Kenudson, MD, and Sylvie Lantuejoul, MD, PhD
Posted: November 12, 2019
Determination of PD-L1 expression by immunohistochemistry (IHC) has been widely evaluated in clinical...